目的:探究喷昔洛韦联合阿昔洛韦软膏治疗带状疱疹的疗效及患者疼痛、血清IL-2、IL-6水平变化情况。方法:选取2016年9月至2020年10月间本院收治的142例带状疱疹患者为研究对象,采用简单随机分组法分为观察组和对照组,71例/组。对照组采...目的:探究喷昔洛韦联合阿昔洛韦软膏治疗带状疱疹的疗效及患者疼痛、血清IL-2、IL-6水平变化情况。方法:选取2016年9月至2020年10月间本院收治的142例带状疱疹患者为研究对象,采用简单随机分组法分为观察组和对照组,71例/组。对照组采用常规软膏涂抹治疗,观察组在此基础上给予喷昔洛韦治疗。比较两组疗效、临床症状改善时间(带状疱疹结痂、水疱停止发展、疼痛消失时间);比较治疗前后两组患者神经痛评分(VAS);比较治疗前后两组血清炎症因子[白细胞介素-2(IL-2)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)]变化;比较治疗前后T细胞亚群[T淋巴细胞(T lymphocyte,CD3^(+))、辅助性T细胞(Helper T cells,CD4^(+))、细胞毒性T细胞(Cytotoxic T cells,CD8^(+))、CD4^(+)/CD8^(+)]变化;记录治疗期间不良反应发生率。结果:治疗7d后,观察组治疗有效率高于对照组(P<0.05);观察组临床症状改善时间均短于对照组(P<0.05);治疗后两组VAS评分均降低且观察组低于对照组(P<0.05);治疗后,两组IL-2、IL-10水平和CD3^(+)、CD4^(+)及CD4^(+)/CD8^(+)均升高,且观察组高于对照组(P<0.05);两组IL-6水平均下降,且观察组低于对照组(P<0.05)。治疗期间两组不良反应发生率无明显差异(P>0.05)。结论:喷昔洛韦联合阿昔洛韦软膏治疗带状疱疹的疗效显著,能缓解神经疼痛,缩短症状消退时间,调节炎症因子,提高免疫功能,且安全性高。展开更多
Objective To investigate the effects of buccal acupuncture on analgesia,immune indicators,and expression levels of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.Methods Eighty patien...Objective To investigate the effects of buccal acupuncture on analgesia,immune indicators,and expression levels of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.Methods Eighty patients with advanced-stage primary liver cancer were selected and divided into control and treatment groups according to the difference in treatment modalities,with 40 patients in each group.The control group received transcatheter arterial chemoembolization(TACE),and the treatment group received buccal acupuncture in addition to TACE.The recent efficacy,analgesic effect,liver function,serum tumor markers,Survivin and Livin protein expression levels in liver cancer tissue,and immune indexes were analyzed and compared between the two groups.Results The objective response rate(ORR)and disease control rate(DCR)of the treatment group were 37.5%and 77.5%,respectively,which were significantly higher than those of the control group(22.5%and 52.5%),and the recent efficacy of the treatment group was significantly better than that of the control group(P<0.05).The onset of analgesia in the treatment group was significantly faster than that in the control group(P<0.05),the duration of analgesia was significantly longer than that in the control group(P<0.05),and the numeric rating scale(NRS)score of pain after treatment was significantly lower than that in the control group(P<0.05).In the treatment group,the aspartate aminotransferase(AST),alanine aminotransferase(ALT),and albumin/globulin(A/G)were significantly lower than those in the control group(P<0.05),and the serum levels of alpha-fetoprotein(AFP),alpha-L-fucosidase(AFU),and carcinoembryonic antigen(CEA)were significantly lower than those in the control group(P<0.05),and the expression levels of Survivin and Livin in liver cancer tissue were significantly lower than those in the control group(P<0.05);CD4^(+)and CD4^(+)/CD8+in the treatment group were significantly higher than those in the control group,and CD8+was significantly lower than that in the control gr展开更多
文摘目的:探究喷昔洛韦联合阿昔洛韦软膏治疗带状疱疹的疗效及患者疼痛、血清IL-2、IL-6水平变化情况。方法:选取2016年9月至2020年10月间本院收治的142例带状疱疹患者为研究对象,采用简单随机分组法分为观察组和对照组,71例/组。对照组采用常规软膏涂抹治疗,观察组在此基础上给予喷昔洛韦治疗。比较两组疗效、临床症状改善时间(带状疱疹结痂、水疱停止发展、疼痛消失时间);比较治疗前后两组患者神经痛评分(VAS);比较治疗前后两组血清炎症因子[白细胞介素-2(IL-2)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)]变化;比较治疗前后T细胞亚群[T淋巴细胞(T lymphocyte,CD3^(+))、辅助性T细胞(Helper T cells,CD4^(+))、细胞毒性T细胞(Cytotoxic T cells,CD8^(+))、CD4^(+)/CD8^(+)]变化;记录治疗期间不良反应发生率。结果:治疗7d后,观察组治疗有效率高于对照组(P<0.05);观察组临床症状改善时间均短于对照组(P<0.05);治疗后两组VAS评分均降低且观察组低于对照组(P<0.05);治疗后,两组IL-2、IL-10水平和CD3^(+)、CD4^(+)及CD4^(+)/CD8^(+)均升高,且观察组高于对照组(P<0.05);两组IL-6水平均下降,且观察组低于对照组(P<0.05)。治疗期间两组不良反应发生率无明显差异(P>0.05)。结论:喷昔洛韦联合阿昔洛韦软膏治疗带状疱疹的疗效显著,能缓解神经疼痛,缩短症状消退时间,调节炎症因子,提高免疫功能,且安全性高。
文摘Objective To investigate the effects of buccal acupuncture on analgesia,immune indicators,and expression levels of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.Methods Eighty patients with advanced-stage primary liver cancer were selected and divided into control and treatment groups according to the difference in treatment modalities,with 40 patients in each group.The control group received transcatheter arterial chemoembolization(TACE),and the treatment group received buccal acupuncture in addition to TACE.The recent efficacy,analgesic effect,liver function,serum tumor markers,Survivin and Livin protein expression levels in liver cancer tissue,and immune indexes were analyzed and compared between the two groups.Results The objective response rate(ORR)and disease control rate(DCR)of the treatment group were 37.5%and 77.5%,respectively,which were significantly higher than those of the control group(22.5%and 52.5%),and the recent efficacy of the treatment group was significantly better than that of the control group(P<0.05).The onset of analgesia in the treatment group was significantly faster than that in the control group(P<0.05),the duration of analgesia was significantly longer than that in the control group(P<0.05),and the numeric rating scale(NRS)score of pain after treatment was significantly lower than that in the control group(P<0.05).In the treatment group,the aspartate aminotransferase(AST),alanine aminotransferase(ALT),and albumin/globulin(A/G)were significantly lower than those in the control group(P<0.05),and the serum levels of alpha-fetoprotein(AFP),alpha-L-fucosidase(AFU),and carcinoembryonic antigen(CEA)were significantly lower than those in the control group(P<0.05),and the expression levels of Survivin and Livin in liver cancer tissue were significantly lower than those in the control group(P<0.05);CD4^(+)and CD4^(+)/CD8+in the treatment group were significantly higher than those in the control group,and CD8+was significantly lower than that in the control gr
